Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

VYNE advances development of FMX-114 combination topical gel for AD

March 3, 2021

Fighting Staphylococcus with Staphylococcus

March 3, 2021

Kymera begins dosing in first-in-human study of KT-474 for atopic dermatitis or HS

March 2, 2021

Hoth advances site recruitment for first-in-human study of BioLexa for atopic dermatitis

March 2, 2021

Aslan reports promising clinical data on ASLAN-004 in atopic dermatitis

March 1, 2021

Celldex plans clinical study of CDX-0159 in prurigo nodularis

Feb. 23, 2021

Phase II study of Thykamine in atopic dermatitis meets its primary endpoint

Feb. 19, 2021

Phase II study of KHK-4083 in atopic dermatitis meets primary endpoint

Feb. 19, 2021

vTv initiates phase I study of PDE4 inhibitor HPP-737 for psoriasis

Feb. 18, 2021

Phase III studies show superiority of topical tirbanibulin to vehicle in actinic keratosis

Feb. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...